Who is at risk
- Smoking is the single biggest cause — chemicals are filtered by the kidneys and sit in contact with the bladder lining. It accounts for roughly half of cases.
- Workplace chemicals — aromatic amines in dye, rubber, leather, paint and printing work. Risk can appear decades after exposure.
- Age and sex — most common after 55, and about four times more common in men.
- Chronic bladder irritation — long-term catheters, repeated infections, schistosomiasis in endemic regions.
- Prior pelvic radiation or certain chemotherapy drugs (cyclophosphamide).
- Family history and Lynch syndrome, which also raises upper urinary tract risk.
Finding it early
Blood in the urine is the symptom that matters, and the one most often explained away. It may be visible or found on a dip test. It is usually painless. It often comes and goes — and the fact that it stopped means nothing at all. In an adult over 35, visible blood in the urine warrants evaluation even if it happened once.
There is no routine screening test for bladder cancer in the general population — it is not common enough for population screening to do more good than harm. That places the whole burden on responding to symptoms.
Other symptoms: needing to pass urine urgently or frequently, burning without infection, or an infection that keeps returning despite treatment. A urinary infection that will not settle in an older adult deserves a look at the bladder.
People with heavy occupational exposure are sometimes surveilled with urine testing — discuss it if that describes your working life.
How it’s diagnosed
Cystoscopy is the definitive test: a thin camera passed into the bladder, usually under local anaesthetic, which sees the lining directly. Urine is also examined for cancer cells, and a CT urogram images the kidneys and ureters.
If a tumor is seen, the next step is TURBT — transurethral resection of bladder tumor — done under anaesthetic, which both removes the visible tumor and provides the tissue that determines everything else. The critical question the pathologist answers is whether the tumor has invaded the muscle wall. That single fact splits bladder cancer into two very different diseases.
Ask specifically whether muscle was included in the specimen — if it was not, the depth cannot be judged reliably and a repeat resection is often advised.
Staging explained simply
Everything hinges on one question: muscle-invasive or not? Non-muscle-invasive disease is treated through the cystoscope and managed like a chronic condition needing lifelong surveillance. Muscle-invasive disease needs aggressive treatment aimed at cure.
| Stage | What it means in plain words |
|---|---|
| Stage 0 | On the surface of the lining — either a small growth (Ta) or flat carcinoma in situ (CIS). Not invasive, but CIS is aggressive and needs treatment. |
| Stage I | Grown into the connective tissue under the lining, but not into muscle. |
| Stage II | Invaded the bladder's muscle wall. This is the dividing line that changes treatment completely. |
| Stage III | Grown through the muscle into surrounding fat or nearby organs, or into nearby lymph nodes. |
| Stage IV | Spread to the pelvic wall, distant lymph nodes or distant organs. |
Grading and biology
Bladder cancer grade is reported simply as low grade or high grade, and here grade carries unusual weight. A low-grade non-invasive tumor tends to recur but rarely threatens life. A high-grade tumor — even a flat, non-invasive one — can progress to invasion and is treated far more seriously.
Carcinoma in situ (CIS) deserves special mention: it is flat, easy to miss, always high grade, and needs treatment even though it has not invaded.
How it’s treated
Non-muscle-invasive disease is treated by resection through the cystoscope, often followed by medicine instilled directly into the bladder — BCG (an immune stimulant) or chemotherapy — to lower the chance of recurrence and progression. Then surveillance cystoscopy, for years.
Muscle-invasive disease has two curative paths, and patients are often not told there are two. One is chemotherapy followed by removal of the bladder (radical cystectomy) with reconstruction. The other is bladder preservation (trimodality therapy): maximal resection, then radiation given with chemotherapy, keeping the bladder in place. In appropriately selected patients, outcomes are comparable, and preserving a working bladder is not a small thing.
Advanced disease is treated with chemotherapy, immunotherapy, and newer antibody-drug conjugates and targeted agents.
Where CureRays fits: bladder preservation is a radiation-led treatment. If you have muscle-invasive bladder cancer and have only been offered removal of the bladder, it is entirely reasonable to ask for a radiation oncology opinion before deciding.
What the guidelines say
In broad strokes: resect and stage accurately, ensuring muscle is in the specimen; treat non-muscle-invasive disease with intravesical therapy chosen by risk and then surveil; for muscle-invasive disease offer chemotherapy before either cystectomy or bladder-preserving chemoradiation, discussed as genuine alternatives; and use immunotherapy and newer agents in advanced disease.
Your team will follow national guidelines such as those from the National Comprehensive Cancer Network (NCCN). The above is a plain-language overview of the general approach, not the guideline itself — your own plan may reasonably differ. NCCN publishes free NCCN Guidelines for Patients®.
Outcomes and odds of cure
Source: NCI SEER Cancer Stat Facts: Bladder Cancer, SEER 21 (excluding IL), 2015–2021. Overall 5-year relative survival is 79.0%.
| When it is found | Share of cases | 5-year relative survival |
|---|---|---|
| In situ — only in the lining | 50% | 97.9% |
| Localized — confined to the bladder | 34% | 72.6% |
| Regional — spread to nearby lymph nodes | 7% | 40.5% |
| Distant — spread to other organs | 6% | 9.1% |
| Unstaged | 3% | 51.5% |
These are population statistics from the National Cancer Institute's SEER program. They describe large groups of people, not any one person, and lag current treatment by several years. They cannot predict what will happen to you.
Side effects and how we watch for them
BCG and intravesical chemotherapy commonly cause urinary burning, urgency and flu-like symptoms for a day or two after each instillation. A high fever or symptoms lasting beyond that should be reported — BCG can rarely cause a systemic infection.
Bladder radiation causes urinary frequency and urgency and some bowel irritation during treatment, settling over the weeks after. A minority have lasting reduction in bladder capacity.
Cystectomy is major surgery with a permanent change in how you pass urine, plus effects on sexual function.
How it is assessed: graded at each visit on a standard scale. Report fever, inability to pass urine, or heavy bleeding urgently.
Follow-up, remission and survivorship
Bladder cancer has the most demanding surveillance in oncology, because non-muscle-invasive disease recurs often. Expect cystoscopy every 3 months at first, stretching out over years if all is clear — frequently for life. It is tedious, and it is what keeps a recurrence from becoming an invasion.
After bladder preservation, surveillance includes cystoscopy as well as imaging. After cystectomy, follow-up focuses on imaging, kidney function and vitamin B12.
Stopping smoking after diagnosis measurably lowers recurrence. Of everything on this page, that is the item most within your control.
Questions people actually ask
I saw blood once and it went away. Do I still need checking?
Yes. Bladder cancer bleeds intermittently — the bleeding stopping tells you nothing about whether a tumor is there. One episode of visible blood in an adult over 35 warrants evaluation.
Can I keep my bladder?
Often, yes. Non-muscle-invasive disease is treated through the cystoscope. For muscle-invasive disease, trimodality therapy — resection plus chemoradiation — preserves the bladder in suitable patients with comparable outcomes. Ask for a radiation oncology opinion.
Why so many cystoscopies?
Because recurrence is common and almost always treatable when caught small. Surveillance is the price of keeping a bladder that works.
What is BCG and why a tuberculosis vaccine?
BCG placed in the bladder provokes a local immune response that attacks residual cancer cells. It is one of the oldest and most effective immunotherapies in medicine.
Does quitting smoking still help after diagnosis?
Yes — it lowers the chance of recurrence and of a second cancer. It is worth doing at any point.
Informational only, not medical advice — confirm with your care team.
Go deeper on bladder cancer
Read the full plain-language guide, or ask us about bladder-preserving treatment.